Heparin and thromboplastin. 1954

R L MACMILLAN, and K W BROWN

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

R L MACMILLAN, and K W BROWN
January 1959, Nature,
R L MACMILLAN, and K W BROWN
April 1979, American journal of clinical pathology,
R L MACMILLAN, and K W BROWN
July 1961, Thrombosis et diathesis haemorrhagica,
R L MACMILLAN, and K W BROWN
March 1971, American journal of clinical pathology,
R L MACMILLAN, and K W BROWN
June 1978, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
R L MACMILLAN, and K W BROWN
January 1980, British journal of haematology,
R L MACMILLAN, and K W BROWN
October 1978, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
R L MACMILLAN, and K W BROWN
June 1998, Archives of internal medicine,
R L MACMILLAN, and K W BROWN
April 1963, Thrombosis et diathesis haemorrhagica,
Copied contents to your clipboard!